CN1723986A - Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art - Google Patents

Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art Download PDF

Info

Publication number
CN1723986A
CN1723986A CN 200510031693 CN200510031693A CN1723986A CN 1723986 A CN1723986 A CN 1723986A CN 200510031693 CN200510031693 CN 200510031693 CN 200510031693 A CN200510031693 A CN 200510031693A CN 1723986 A CN1723986 A CN 1723986A
Authority
CN
China
Prior art keywords
water
add
decocted
time
body resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510031693
Other languages
Chinese (zh)
Other versions
CN100337643C (en
Inventor
罗瑞锋
邓志方
姜新宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Warburg Pharmaceutical Co. Ltd.
Original Assignee
HUNAN LUSHAN NATURAL PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNAN LUSHAN NATURAL PHARMACEUTICAL CO Ltd filed Critical HUNAN LUSHAN NATURAL PHARMACEUTICAL CO Ltd
Priority to CNB2005100316931A priority Critical patent/CN100337643C/en
Publication of CN1723986A publication Critical patent/CN1723986A/en
Application granted granted Critical
Publication of CN100337643C publication Critical patent/CN100337643C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in the form of effervescent tablet for strengthening human body resistance is proportionally prepared from the extracts of astragalus root and lucid ligustrum fruit, lactose, rebaudiose, tartaric acid, sodium dicarbonate, poly ethanediol and magnesium stearate. Its preparing process is also disclosed.

Description

Body resistance-strengthening Zhenqi effervescent tablet and preparation technology thereof
Technical field
The present invention relates to body resistance-strengthening Zhenqi effervescent tablet and preparation technology thereof.
Background technology
The like product of domestic production at present mainly contains ZHENQI FUZHENG KELI.ZHENQI FUZHENG KELI is made up of the Radix Astragali, Fructus Ligustri Lucidi, and the Radix Astragali is given birth to and used invigorating QI to consolidate the body surface resistance, diuresis toxin expelling, evacuation of pus, expelling pus and promoting granulation.The Fructus Ligustri Lucidi nourishing the liver and kidney, black hair makes eye bright.All medicines share boosting qi and nourishing yin.ZHENQI FUZHENG KELI is the kind of recording in the 20 of Ministry of Health of the People's Republic of China's " Chinese traditional patent formulation preparation "; The raising immune function of human body is arranged, protection bone marrow and adrenal cortex function; What be used for that various diseases causes is deficient; Cooperate operation, lonizing radiation, chemotherapy, promote the effect of the recovery of normal function.But ZHENQI FUZHENG KELI is because adjuvant is more, and dosage is big, and it is big that patient takes volume, carries and take inconvenience, and the sugar content height, and dissolving is slow, stores, transportation is also inconvenient.In addition, technical process that former preparation technology mentions is simple, and the technology that much helps improving the quality does not all provide out, thereby unfavorable product quality is stable.
Summary of the invention
It is better that purpose of the present invention aims to provide a kind of product quality, have that disintegration time is short, the medicine stripping rapidly, absorb fast, bioavailability is high, drug dose is accurate, takes, easy to carry, especially is fit to the body resistance-strengthening Zhenqi effervescent tablet that old people, child and dysphagia patients use.
It is more complete that another object of the present invention aims to provide a kind of preparation technology, more perfect, more helps the raising of product quality level, saves cost, can carry out the preparation technology of the body resistance-strengthening Zhenqi effervescent tablet of large-scale industrial production.
The objective of the invention is to realize by following manner:
Body resistance-strengthening Zhenqi effervescent tablet weight proportion of the present invention is: dried cream powder 900-970 part of the Radix Astragali, Fructus Ligustri Lucidi, lactose 430-490 part, steviosin 5-20 part, tartaric acid 200-280 part, sodium bicarbonate 200-240 part, polyethylene glycol 6000,80-120 part, magnesium stearate 8-12 part.
The present invention is in 1000, and preferable weight proportion is: the dried cream powder 945g of the Radix Astragali, Fructus Ligustri Lucidi, lactose 475g, steviosin 10g, tartaric acid 240g, sodium bicarbonate 220g, polyethylene glycol 6000,100g, magnesium stearate 10g.
The weight proportion of the Radix Astragali, Fructus Ligustri Lucidi is 2: 1.
Another object of the present invention realizes by following manner: the Radix Astragali, Fructus Ligustri Lucidi, decoct with water three times, and add water 8-12 for the first time and doubly measure, decocted 2-3 hour; For the second time add water 6-10 and doubly measure, decocted 1-2 hour; Add water 6-10 for the third time and doubly measure, decocted 0.5-1 hour; Filter, merging filtrate is evaporated to relative density 1.08-1.10 (60 ℃ of surveys), and spray drying gets dry extract;
Get dried cream, add lactose, tartaric acid, steviosin, mix, be ground into fine powder,, granulate with ethanol system soft material, 60-65 ℃ of drying, granulate, standby; Taking polyethylene glycol-6000 fusion in addition adds sodium bicarbonate, stirs, and is ground into fine powder after the cooling, sieves, with above-mentioned granulates, magnesium stearate mixing, tabletting.
The preparation technology of the best of the present invention is:
The Radix Astragali, Fructus Ligustri Lucidi decoct with water three times, add 10 times of amounts of water for the first time, decoct 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours; Add 8 times of amounts of water for the third time, decocted 1 hour; Filter, merging filtrate is evaporated to relative density 1.08-1.10 (60 ℃ of surveys), and spray drying gets dry extract;
Get dried cream, add lactose, tartaric acid, steviosin, mix, be ground into fine powder,, granulate with ethanol system soft material, 60-65 ℃ of drying, granulate, standby; Taking polyethylene glycol-6000 fusion in addition adds sodium bicarbonate, stirs, and is ground into fine powder after the cooling, sieves, with above-mentioned granulates, magnesium stearate mixing, tabletting.
Described concentrating under reduced pressure is at 60-65 ℃, and vacuum is to carry out under the 0.07-0.09Mpa.
The extraction process of former ZHENQI FUZHENG KELI is: get the Radix Astragali, Fructus Ligustri Lucidi decocts with water three times, collecting decoction filters, and filtrate concentrates clear paste.The water extraction process condition only has extraction time, decocting time, but lacks amount of water, and they are the key factors that influence extraction effect.Amount of water after the present invention not only clearly proposes to optimize, and can make technology more complete, extraction effect is better, not only save cost, and active ingredient is kept fully also.
Show that by test dry extract yield of the present invention can reach 21.5%, Radix Astragali active ingredient first glycosides extracted amount can reach 126.9mg.Can reach energy-saving and cost-reducing preferably, the effect of increasing work efficiency.In addition, the present invention is at 60-65 ℃, and vacuum is that drying under reduced pressure can reach the effective ingredient that does not as far as possible destroy in the medicinal liquid under the 0.07-0.09Mpa, with the effect of the quality that guarantees finished product.The present invention also adopts spray drying, thereby drying time is short, the drying efficiency height, and the dried cream of gained is crisp, of light color, and melting is good, the Astragaloside content height.Thereby improved end product quality, also saved the production time.
The present invention adopts sodium bicarbonate can make effervescent tablet disintegrate rapidly in water as alkali source, and the pH value of effervescent solution is lower.With sodium bicarbonate as alkali source after, because acid source has citric acid, tartaric acid, fumaric acid, malic acid etc., the present invention determines to adopt tartaric acid can be used as and is fit to best adjuvant of the present invention through multiple comparison test, at granulation, tabletting, all there is good effect aspects such as effervescent.The present invention adopts tartaric acid and medicated powder, lactose to mix granulation, do not lump in the time of can making drug particles dry, and good tabletting, effervescent is effective.The present invention adopts lactose both water-soluble, no hygroscopicity, and stable in properties again, and moisture resistance is good, does not chemically react with most drug, and the tablet surface of making is bright and clean attractive in appearance.
Because Polyethylene Glycol in the moulding process of the present invention-6000 packing technology research is very big to the hardness influence of effervescent tablet, this technology if be provided with preferably, can cause effervescent tablet to be placed and lose efficacy.Therefore the inventor is therefore to wrapping up and not wrapping up the test of contrasting: if with sodium bicarbonate and the direct mixed pressuring plate of granulates, after placing a period of time, acid interacts with alkali, and slice, thin piece hardness is reduced, therefore need sodium bicarbonate is adopted Polyethylene Glycol-6000 parcel, soda acid is isolated.Parcel by Polyethylene Glycol-6000 that sodium bicarbonate is adopted with do not wrap up two kinds of technologies, respectively at the 0th day firmness change situation, determine whether to adopt the method for the parcel of Polyethylene Glycol-6000 with the 30th day investigation tablet.The results are shown in Table 10:
Table 10: the investigation result of Polyethylene Glycol-6000 packing technology
Technology Hardness (kg)
The 0th day The 30th day
Wrap up 8.57 8.62 8.45 7.38
The result shows: adopt the technology of Polyethylene Glycol-6000 parcel, place after 30 days hardness and do not have significant change.Can place the problem that lost efficacy thereby solve effervescent tablet effectively every acid source and alkali source so adopt the method for polyethylene glycol 6000 parcel.
Thereby Polyethylene Glycol-6000 packing technology that the present invention determines is: after Polyethylene Glycol-6000 fusion, add sodium bicarbonate, stir, pulverized 80 mesh sieves after the cooling, with granulates mixing in proportion, get final product before tabletting.
The present invention compares with the ZHENQI FUZHENG KELI agent, its dosage of original ZHENQI FUZHENG KELI 15g/ bag, one time one bag, every day 2 times, thereby for patient, its dose is obviously bigger, the sugar content height.And dosage 2.0g/ sheet of the present invention, one time 3, every day 2 times, it is little to have a volume of taking, good looking appearance, patient carries, taking convenience, be specially adapted to the patient of child, old people and dysphagia, the present invention has the advantage of tablet and liquid preparation concurrently, takes with the solution form because of it again, drug effect is rapid, the bioavailability height.And because technology of the present invention is more perfect, the quality standard of the product effervescent tablets of gained increases than former ZHENQI FUZHENG KELI agent.
ZHENQI FUZHENG KELI and the present invention are relatively
The above results shows: quality standard of the present invention increases than former dosage form, and the present invention also has advantages such as taking, carry more convenient, patient Geng Yi acceptance.
Finished product yield of the present invention is higher, quality controllable, is fit to industrialized great production.
The specific embodiment
Embodiment 1
Get Radix Astragali 3000g and Fructus Ligustri Lucidi 1500g, decoct with water three times, add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours; Add 8 times of amounts of water for the third time, decocted 1 hour; Filter, merging filtrate, at 60-65 ℃, vacuum is to be evaporated to relative density 1.08-1.10 (60 ℃ of surveys) under the 0.07-0.09Mpa, spray drying, about 945g gets dry extract.
Get dried cream 945g, add lactose 475g, tartaric acid 240g, steviosin 10g, mix, be ground into fine powder,, granulate then with ethanol system soft material, 60-65 ℃ of drying, granulate, standby.Taking polyethylene glycol-6000100g fusion in addition adds sodium bicarbonate 220g, stirs, and is ground into fine powder after the cooling, sieves, and with above-mentioned granulates, magnesium stearate 10g mixing, tabletting, makes 1000 approximately.
Embodiment 2
Get Radix Astragali 3000g and Fructus Ligustri Lucidi 1500g, decoct with water three times, add 8 times of amounts of water for the first time, decocted 2 hours; For the second time add 6 times of amounts of water, decocted 1 hour; Add 6 times of amounts of water for the third time, decocted 0.5 hour; Other step is with embodiment 1.
Embodiment 3
Get Radix Astragali 3000g and Fructus Ligustri Lucidi 1500g, decoct with water three times, add 12 times of amounts of water for the first time, decocted 3 hours; For the second time add 10 times of amounts of water, decocted 2 hours; Add 10 times of amounts of water for the third time, decocted 1 hour; Filter, merging filtrate, other step is with embodiment 1.
Embodiment 4
Other step is got the dried cream powder 900g of the Radix Astragali, Fructus Ligustri Lucidi with embodiment 1, lactose 430g, steviosin 5g, tartaric acid 200g, sodium bicarbonate 200g, polyethylene glycol 6000 80g, magnesium stearate 8g.
Embodiment 5
The dried cream powder 970g of the Radix Astragali, Fructus Ligustri Lucidi, lactose 490g, steviosin 20g, tartaric acid 280g, sodium bicarbonate 240g, polyethylene glycol 6000 120g, magnesium stearate 12g.

Claims (7)

1, body resistance-strengthening Zhenqi effervescent tablet is characterized in that: its weight proportion is: dried cream powder 900-970 part of the Radix Astragali, Fructus Ligustri Lucidi, lactose 430-490 part, steviosin 5-20 part, tartaric acid 200-280 part, sodium bicarbonate 200-240 part, polyethylene glycol 6000 80-120 part, magnesium stearate 8-12 part.
2, body resistance-strengthening Zhenqi effervescent tablet according to claim 1 is characterized in that: in 1000, weight proportion is: the dried cream powder 945g of the Radix Astragali, Fructus Ligustri Lucidi, lactose 475g, steviosin 10g, tartaric acid 240g, sodium bicarbonate 220g, polyethylene glycol 6000 100g, magnesium stearate 10g.
3, body resistance-strengthening Zhenqi effervescent tablet according to claim 1 and 2 is characterized in that: the weight proportion of the Radix Astragali, Fructus Ligustri Lucidi is 2: 1.
4, the technology of the described body resistance-strengthening Zhenqi effervescent tablet of preparation claim 1 is characterized in that: the Radix Astragali, Fructus Ligustri Lucidi, decoct with water three times, and add water 8-12 for the first time and doubly measure, decocted 2-3 hour; For the second time add water 6-10 and doubly measure, decocted 1-2 hour; Add water 6-10 for the third time and doubly measure, decocted 0.5-1 hour; Filter, merging filtrate is evaporated to relative density 1.08-1.10 (60 ℃ of surveys), and spray drying gets dry extract; Get dried cream, add lactose, tartaric acid, steviosin, mix, be ground into fine powder,, granulate with ethanol system soft material, 60-65 ℃ of drying, granulate, standby; Taking polyethylene glycol-6000 fusion in addition adds sodium bicarbonate, stirs, and is ground into fine powder after the cooling, sieves, with above-mentioned granulates, magnesium stearate mixing, tabletting.
5, the preparation technology of body resistance-strengthening Zhenqi effervescent tablet according to claim 4 is characterized in that: the Radix Astragali, Fructus Ligustri Lucidi, decoct with water three times, and add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours; Add 8 times of amounts of water for the third time, decocted 1 hour; Filter, merging filtrate is evaporated to relative density 1.08-1.10 (60 ℃ of surveys), and spray drying gets dry extract; Get dried cream, add lactose, tartaric acid, steviosin, mix, be ground into fine powder,, granulate with ethanol system soft material, 60-65 ℃ of drying, granulate, standby; Taking polyethylene glycol-6000 fusion in addition adds sodium bicarbonate, stirs, and is ground into fine powder after the cooling, sieves, with above-mentioned granulates, magnesium stearate mixing, tabletting.
6, the preparation technology of body resistance-strengthening Zhenqi effervescent tablet according to claim 4 is characterized in that: described concentrating under reduced pressure is at 60-65 ℃, and vacuum is to carry out under the 0.07-0.09Mpa.
7, the preparation technology of body resistance-strengthening Zhenqi effervescent tablet according to claim 4 is characterized in that: get Radix Astragali 3000g and Fructus Ligustri Lucidi 1500g, decoct with water three times, add 10 times of amounts of water for the first time, decocted 3 hours; For the second time add 8 times of amounts of water, decocted 2 hours; Add 8 times of amounts of water for the third time, decocted 1 hour; Filter, merging filtrate, at 60-65 ℃, vacuum is to be evaporated to relative density 1.08-1.10 (60 ℃ of surveys) under the 0.07-0.09Mpa, spray drying, about 945g gets dry extract; Get dried cream 945g, add lactose 475g, tartaric acid 240g, steviosin 10g, mix, be ground into fine powder,, granulate then with ethanol system soft material, 60-65 ℃ of drying, granulate, standby.Taking polyethylene glycol-6000 100g fusion in addition adds sodium bicarbonate 220g, stirs, and is ground into fine powder after the cooling, sieves, and with above-mentioned granulates, magnesium stearate 10g mixing, tabletting, makes 1000.
CNB2005100316931A 2005-06-10 2005-06-10 Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art Active CN100337643C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100316931A CN100337643C (en) 2005-06-10 2005-06-10 Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100316931A CN100337643C (en) 2005-06-10 2005-06-10 Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art

Publications (2)

Publication Number Publication Date
CN1723986A true CN1723986A (en) 2006-01-25
CN100337643C CN100337643C (en) 2007-09-19

Family

ID=35923703

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100316931A Active CN100337643C (en) 2005-06-10 2005-06-10 Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art

Country Status (1)

Country Link
CN (1) CN100337643C (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103585281A (en) * 2013-11-21 2014-02-19 贵州信邦制药股份有限公司 Zhenqi chewable tablets and preparation method thereof
CN103655726A (en) * 2013-12-09 2014-03-26 贵州信邦制药股份有限公司 Syrup prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof
CN103655727A (en) * 2013-12-09 2014-03-26 贵州信邦制药股份有限公司 Condensed pill prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof
CN103720770A (en) * 2013-12-20 2014-04-16 贵州信邦制药股份有限公司 Glossy privet fruit-astragalus membranaceus effervescent preparation and preparation method thereof
CN104096204A (en) * 2014-07-23 2014-10-15 重庆大学 Children lung cough effervescent tablet and preparation method thereof
CN110339238A (en) * 2019-07-29 2019-10-18 江西旭虹药业有限公司 The preparation method of particle is exempted from a kind of stilbene chastity increasing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1456234A (en) * 2003-02-12 2003-11-19 毛友昌 Preparation of weidakang effervescent tablets

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103585281A (en) * 2013-11-21 2014-02-19 贵州信邦制药股份有限公司 Zhenqi chewable tablets and preparation method thereof
CN103655726A (en) * 2013-12-09 2014-03-26 贵州信邦制药股份有限公司 Syrup prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof
CN103655727A (en) * 2013-12-09 2014-03-26 贵州信邦制药股份有限公司 Condensed pill prepared from ligustrum lucidum and radix astragali and capable of reinforcing healthy qi, and preparation method thereof
CN103720770A (en) * 2013-12-20 2014-04-16 贵州信邦制药股份有限公司 Glossy privet fruit-astragalus membranaceus effervescent preparation and preparation method thereof
CN104096204A (en) * 2014-07-23 2014-10-15 重庆大学 Children lung cough effervescent tablet and preparation method thereof
CN104096204B (en) * 2014-07-23 2017-10-13 重庆大学 Lungs of Children coughs effervescent tablet and preparation method thereof
CN110339238A (en) * 2019-07-29 2019-10-18 江西旭虹药业有限公司 The preparation method of particle is exempted from a kind of stilbene chastity increasing

Also Published As

Publication number Publication date
CN100337643C (en) 2007-09-19

Similar Documents

Publication Publication Date Title
CN100518746C (en) Aweto micropowder tablet and preparation method thereof
CN101015571B (en) Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
CN100337643C (en) Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art
CN104435748A (en) Dendrobium officinale compound preparation as well as preparation method and application of dendrobium officinale compound preparation
CN105288215A (en) High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof
CN112021555A (en) Ganoderma lucidum spore powder tablet and preparation method thereof
CN107801999A (en) A kind of folium cortex eucommiae buccal tablet with vasorelaxation action
CN102772444A (en) Method for processing traditional Chinese medicinal ultramicro wall-broken oral tablet slices
CN102552696B (en) Compound diabetes oral preparation and preparation method thereof
CN102772440A (en) Processing method of ultra-micro wall-breaking oral-tablet decoction pieces by traditional Chinese medicines
CN101637561A (en) Fritillary-loquat medicinal composition and preparation method thereof
CN102362966A (en) Unibract fritillary bulb and loquat leaf medicinal composition and preparation method thereof
CN103381193B (en) A kind of Rhodiola rosea micro powder tablet and preparation method thereof
CN1054370A (en) A kind of manufacture method of kidney-tonifying health-care medicament
CN102793839A (en) Taste-modifying Chinese medicinal preparation and preparation method thereof
CN101019898B (en) Crushing method and preparation of aweto
CN103830674A (en) Medicament composition for treating lipomyoma and preparation method and application thereof
CN1927342A (en) Heat clearing and detoxicating dispersant tablet and method for making same
CN1224354C (en) Preparation method for health food compounded by Asparagus sprengreri, ginseng fibrous root, lily bulb and officinal dendrobium stem
CN107854671A (en) A Na series anaesthetic intragastric floating sustained-release preparations and preparation method thereof
CN101822796B (en) Silver ice buccal tablet, and preparation method and application thereof
CN111450138A (en) Astragalus root effervescent tablet and preparation process thereof
CN1660191A (en) Oral preparation of Chinese traditional medicine for treating vascular headache and hemicrania, and preparation method
CN101491580A (en) Combination with blood sugar reducing function and preparation method thereof
CN1672704A (en) Erosion-eliminating effervescent tablet and its prepn

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: WANBANGDE (HUNAN) NATURAL PHARMACEUTICAL CO., LTD.

Free format text: FORMER NAME: LUSHAN NATURAL PLANT PHARMACEUTICAL CO., LTD., HU NAN

CP03 Change of name, title or address

Address after: 410331 No. 99, Kangping Road, Changsha national biological industry base, Changsha, Hunan

Patentee after: Wan Bangde (Hunan) Natural Medicine Co., Ltd.

Address before: 410329 Liuyang City, Hunan province Liuyang biomedical park Hunan Lushan Natural Pharmaceutical Co Ltd

Patentee before: Hunan Lushan Natural Pharmaceutical Co., Ltd.

C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: 410331 No. 99, Kangping Road, Changsha national biological industry base, Changsha, Hunan

Patentee after: Hunan Warburg Pharmaceutical Co. Ltd.

Address before: 410331 No. 99, Kangping Road, Changsha national biological industry base, Changsha, Hunan

Patentee before: Wan Bangde (Hunan) Natural Medicine Co., Ltd.